<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92500">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01900756</url>
  </required_header>
  <id_info>
    <org_study_id>1U01NS079179</org_study_id>
    <nct_id>NCT01900756</nct_id>
  </id_info>
  <brief_title>Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke</brief_title>
  <acronym>THRIVES</acronym>
  <official_title>Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a culturally-sensitive multipronged
      post-discharge intervention can significantly reduce blood pressure, enhance achievement of
      guideline recommended targets for risk factor control, and lower recurrent vascular events
      in a low-income and middle-income (LMIC). The study will have 2 Phases - a qualitative phase
      (Phase 1) lasting less than one year involving development of the intervention through focus
      group methodologies and structured interviews, and a clinical trial phase (Phase 2)lasting 3
      years involving a randomized trial testing the efficacy of the intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research seeks to develop an effective and sustainable way of reducing the devastating
      and deadly impact of stroke in a low-income region of the world with poor medical
      infrastructure. It will do so by focusing on improving the treatment of the condition most
      closely tied to stroke, hypertension, using novel methods that incorporate the input of the
      local community. If successful, the strategy could serve as a ready model to be adapted by
      decision-makers in other under-resourced areas for lessening the burden of stroke(and other
      major public health challenges).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in systolic blood pressure</measure>
    <time_frame>1 year</time_frame>
    <description>Reduction in systolic blood pressure at one year post-discharge in stroke patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduced rate of subsequent primary vascular event</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Reduction of disability and enhanced quality of life.</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Behavioral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pre-appointment phone text
In-clinic educational video
Patient report card
Post-clinic phone text
Outpatient stroke registry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine and customary management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>THRIVES</intervention_name>
    <description>Pre-appointment phone text In-clinic educational video Patient report card Post-clinic phone text Outpatient stroke registry</description>
    <arm_group_label>Behavioral</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Phase 1: Inclusion Criteria:

        Age ≥ 18 years Stroke within one year access to mobile phone.

        Exclusion Criteria:

        Any medical condition that would limit participation in follow up assessments, Severe
        cognitive impairment/dementia (MMSE ≤24) Severe global disability (modified Rankin Score ≥
        3).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sacred Heart Hospital</name>
      <address>
        <city>Abeokuta</city>
        <state>Ogun</state>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rufus Akinyemi, MD</last_name>
      <email>rufusakinyemi@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Tunde Sowole, MD</last_name>
      <email>sowman2001@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rufus Akinyemi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal Medical Centre</name>
      <address>
        <city>Abeokuta</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rufus Akinyemi, MD</last_name>
      <phone>07056790001-3</phone>
      <email>fmcabk@yahoo.net</email>
    </contact>
    <investigator>
      <last_name>Rufus Akinyemi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University College Hospital</name>
      <address>
        <city>Ibadan</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayowa Owalabi, MD</last_name>
      <phone>08023038583</phone>
    </contact>
    <investigator>
      <last_name>Mayowa Owalabi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>May 3, 2016</lastchanged_date>
  <firstreceived_date>July 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
